♦Vinblastine



♦Vinblastine





(vin-blas’-teen)

Velban, VLB

Pregnancy Category D


Mechanism of Action

A cell cycle-specific vinca alkaloid that inhibits mitotic spindle formation by binding to tubulin. Most specific for the M phase.


Indications

Hodgkin’s lymphoma, lymphoma, testicular carcinoma, Kaposi’s sarcoma, mycosis fungoides, breast carcinoma.



Metabolism/Excretion

Metabolized in the liver; excreted in bile.


Dosage Range

♦ Initial therapy: single IV dose once weekly. Guidelines are as follows:

















Dose Adult/Pediatric

1


2


3


4


5


3.7/2.5 mg/m2


5.5/3.75 mg/m2


7.4/5.0 mg/m2


9.25/6.25 mg/m2


11.1/7.5 mg/m2

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in ONCOLOGY | Comments Off on ♦Vinblastine

Full access? Get Clinical Tree

Get Clinical Tree app for offline access